XYL financials

Xylem Inc. · end-of-day data as of Oct 16, 2026

Xylem Inc.

XYL · $24.3B

$104.05-12.8%last 60 sessions · close Oct 16, 2026

$100.88$150.8352 weeks

Buy · 21 analystsPT $148.26 +42.5%

P/E vs own-24.1%
P/E vs sector-13.1%
Target upside+42.5%
Off 52w high-31.0%
InsidersNone in 90d
FCF yield+4.0%
Earnings in11d
Trendbullish
Sector→ -7.1%
RSI47
MA20×50↑ in ~48d
Volume1.1x
Support-3.1%
Resistance+2.3%

XYL reported revenue of $2.34B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 1.5% from a year earlier. It posted diluted EPS of $1.11, free cash flow of $201M and a net margin of 11.3%.

Valuation

P/E24.8x
P/E vs own-24.1%
P/E vs sector-13.1%
FCF yield+4.0%
Market cap$24.3B

Quarterly results

Q2 FY2026: Revenue +1.5% year over year, free cash flow 8.6% of revenue, operating margin 16.7%.

RevenueFree cash flow


Q2 FY2026	Jun 30, 2026	$2.34B	1.11	$201M	41.2%	16.7%	11.3%
Q1 FY2026	Mar 31, 2026	$2.13B	0.79	$18M	37.8%	11.5%	8.7%
Q4 FY2025	Dec 31, 2025	$2.4B	1.37	$460M	38.9%	14.7%	14.0%
Q3 FY2025	Sep 30, 2025	$2.27B	0.93	$281M	38.9%	14.7%	10.0%
Q2 FY2025	Jun 30, 2025	$2.3B	0.93	$207M	38.8%	13.3%	9.8%
Q1 FY2025	Mar 31, 2025	$2.07B	0.69	-$38M	37.1%	11.2%	8.2%
Q4 FY2024	Dec 31, 2024	$2.26B	1.34	$475M	38.0%	11.8%	14.5%
Q3 FY2024	Sep 30, 2024	$2.1B	0.89	$237M	37.3%	13.3%	10.3%
Q2 FY2024	Jun 30, 2024	$2.17B	0.80	$215M	37.8%	11.7%	8.9%
Q1 FY2024	Mar 31, 2024	$2.03B	0.63	$15M	37.0%	10.3%	7.5%
Q4 FY2023	Dec 31, 2023	$2.12B	1.10	$361M	35.7%	10.0%	12.6%
Q3 FY2023	Sep 30, 2023	$2.08B	0.63	$299M	36.8%	9.2%	7.3%